Medication switch
Switching from Wegovy to Zepbound
semaglutide → tirzepatide — re-titration required
Semaglutide → tirzepatide for weight loss — strongest head-to-head data favors tirzepatide.
Medically reviewed by Dr. Jane Novak, MD, MPH on May 15, 2026
Cross-ingredient switch — re-titration required
Wegovy uses semaglutide; Zepbound uses tirzepatide. You restart from the starter dose and re-titrate over 12–20 weeks to reduce GI side effects.
Why patients make this switch
- 1Plateau on max Wegovy 2.4 mg dose with goal weight not reached.
- 2SURMOUNT-5 head-to-head data shows tirzepatide achieves greater mean weight loss.
- 3Wegovy starter-dose shortage during 2024-2026 made initiation difficult.
- 4LillyDirect self-pay vials offer cheaper option than Wegovy pens.
Dose transition
These medications use different active ingredients (semaglutide vs. tirzepatide). Re-titration from the starter dose is required to reduce GI side effects.
Timeline & titration
Start Zepbound 2.5 mg for 4 weeks then escalate to 5 mg → 7.5 mg → 10 mg → 12.5 mg → 15 mg as tolerated. Most patients stabilize at 10 mg or 15 mg for weight management. Full titration from Wegovy 2.4 mg to Zepbound 15 mg is 20 weeks.
Side-effect transition
Expect nausea and constipation to return during re-titration. The SURMOUNT trials show side-effect rates similar between products at maintenance — the difference is the re-titration period.
Insurance & cost
Zepbound PA same as Wegovy. Some insurers may consider it a "switch within class" and require new step-through documentation. LillyDirect self-pay vials at $349-$549/month are an option Wegovy does not offer.
When this switch is NOT recommended
- You are losing weight steadily on Wegovy and tolerating it well.
- You cannot afford a 12-20 week titration plateau before reaching the new maintenance dose.
Switching to Zepbound? Book a telehealth visit.
Our ranked telehealth providers handle switching prescriptions, prior authorizations, and pharmacy coordination — typically 1–3 business days end to end.
See top providersEditorial ranking is independent of commission rates.
Frequently asked questions
Is Zepbound better than Wegovy for weight loss?
In the SURMOUNT-5 head-to-head trial (Aronne et al., NEJM 2025), tirzepatide 15 mg achieved 20.2% mean weight loss vs. semaglutide 2.4 mg at 14.3% over 72 weeks. Individual response varies; the trial does not predict outcomes in every patient.
Other switching guides
Reverse direction
Zepbound → Wegovy
Other from Wegovy
Wegovy → Ozempic
Other from Wegovy
Wegovy → Mounjaro
Other to Zepbound
Mounjaro → Zepbound
Other to Zepbound
Ozempic → Zepbound
Keep exploring
Resources for patients moving from Wegovy to Zepbound.
Drug overview
Zepbound — uses, dose, side effects
FDA-label overview of Zepbound (tirzepatide) with dosing schedule and contraindications.
ReadDrug overview
Wegovy — full review
What you're switching from. Pricing, indications, and patient experience.
ReadLive data
FDA shortage tracker
Check current Zepbound availability and which doses are limited.
ReadFree tool
Are you a GLP-1 candidate?
Decision tree based on FDA criteria. Flags contraindications.
ReadFree tool
Prior auth letter generator
Draft a payer-ready PA letter your prescriber can sign in minutes.
ReadRanked & reviewed
Top GLP-1 providers for 2026
Telehealth providers ranked by price, ratings, and insurance.
Read
Common questions readers ask
- Can you drink alcohol on Wegovy?
- No hard contraindication, but alcohol tolerance often drops sharply on GLP-1. Many patients also report reduced desire for alcohol — likely a secondary effect of GLP-1 on the brain reward system. Full evidence-graded answer
- Does GLP-1 affect oral birth control?
- Tirzepatide (Mounjaro, Zepbound) has documented reduced absorption of oral contraceptives during the first 4 weeks of each dose increase. Use backup contraception for ~4 weeks after starting + after each step-up. Semaglutide has no documented effect. Full evidence-graded answer
- Can I take GLP-1 while pregnant?
- No. All FDA-approved GLP-1s carry a pregnancy contraindication. Stop GLP-1 at least 2 months before planned conception due to its long half-life. Full evidence-graded answer
- Is it safe to take GLP-1 long-term?
- Liraglutide has 15+ years of post-marketing data (Victoza approved 2010). Semaglutide has 8+ years (Ozempic approved 2017). No new class-wide safety signals have emerged in extended follow-up. Chronic use is the FDA-approved indication for both T2D and obesity. Full evidence-graded answer
- Do I need to exercise on Wegovy?
- Yes — resistance training specifically. Without it, 25-40% of weight lost on GLP-1 comes from lean muscle. Cardio is a bonus; resistance is the non-negotiable. Full evidence-graded answer